
Are Robust Financials Driving The Recent Rally In Impro Precision Industries Limited's (HKG:1286) Stock?

Impro Precision Industries Limited's stock has surged 47% in three months, driven by strong financials, particularly a high ROE of 13%. This ROE surpasses the industry average of 8.8%, contributing to a 33% net income growth over five years. Despite a high payout ratio, the company maintains impressive earnings growth, though future growth may slow as per analyst forecasts.
Impro Precision Industries' (HKG:1286) stock is up by a considerable 47% over the past three months. Since the market usually pay for a company’s long-term fundamentals, we decided to study the company’s key performance indicators to see if they could be influencing the market. Particularly, we will be paying attention to Impro Precision Industries' ROE today.
Return on Equity or ROE is a test of how effectively a company is growing its value and managing investors’ money. In other words, it is a profitability ratio which measures the rate of return on the capital provided by the company's shareholders.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
How Is ROE Calculated?
Return on equity can be calculated by using the formula:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
So, based on the above formula, the ROE for Impro Precision Industries is:
13% = HK$688m ÷ HK$5.3b (Based on the trailing twelve months to June 2025).
The 'return' is the yearly profit. One way to conceptualize this is that for each HK$1 of shareholders' capital it has, the company made HK$0.13 in profit.
View our latest analysis for Impro Precision Industries
What Has ROE Got To Do With Earnings Growth?
So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company’s earnings growth potential. Assuming everything else remains unchanged, the higher the ROE and profit retention, the higher the growth rate of a company compared to companies that don't necessarily bear these characteristics.
Impro Precision Industries' Earnings Growth And 13% ROE
At first glance, Impro Precision Industries seems to have a decent ROE. On comparing with the average industry ROE of 8.8% the company's ROE looks pretty remarkable. Probably as a result of this, Impro Precision Industries was able to see an impressive net income growth of 33% over the last five years. However, there could also be other causes behind this growth. For instance, the company has a low payout ratio or is being managed efficiently.
As a next step, we compared Impro Precision Industries' net income growth with the industry, and pleasingly, we found that the growth seen by the company is higher than the average industry growth of 6.1%.
Earnings growth is an important metric to consider when valuing a stock. The investor should try to establish if the expected growth or decline in earnings, whichever the case may be, is priced in. By doing so, they will have an idea if the stock is headed into clear blue waters or if swampy waters await. What is 1286 worth today? The intrinsic value infographic in our free research report helps visualize whether 1286 is currently mispriced by the market.
Is Impro Precision Industries Using Its Retained Earnings Effectively?
The high three-year median payout ratio of 50% (implying that it keeps only 50% of profits) for Impro Precision Industries suggests that the company's growth wasn't really hampered despite it returning most of the earnings to its shareholders.
Additionally, Impro Precision Industries has paid dividends over a period of six years which means that the company is pretty serious about sharing its profits with shareholders.
Summary
In total, we are pretty happy with Impro Precision Industries' performance. We are particularly impressed by the considerable earnings growth posted by the company, which was likely backed by its high ROE. While the company is paying out most of its earnings as dividends, it has been able to grow its earnings in spite of it, so that's probably a good sign. Having said that, the company's earnings growth is expected to slow down, as forecasted in the current analyst estimates. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.

